




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)
文檔簡介
COVID-19
InfectionPreventionandControl
Livingguideline
Maskuseincommunitysettings
22December2021
WorldHealth
?Organization
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
2of38
Sections
1.
ExecutiveSummary 3
1.1
Abbreviations 3
1.2
Definitions 4
2.
Methodology 5
3.
Advice,statementsandrecommendations 7
3.1
Generalmaskadvice 7
3.2
Maskuseincommunitysettings 7
3.2.1
Maskuseduringphysicalactivity 15
3.2.2
Typeofmaskusedbythegeneralpublic 16
3.3
Maskusebychildren 22
4.
Acknowledgements 29
References 31
WHOcontinuestomonitorthesituationcloselyforanychangesthatmayaffectthislivingguideline.Shouldanyfactorschange,WHOwillissueafurtherupdate.Otherwise,thislivingguidelinewillexpire2yearsafterthedateofpublication.
?WorldHealthOrganization2021.Somerightsreserved.Thisworkisavailableunderthe
CCBY-NC-SA3.0IGOlicence
.WHOreferencenumber:WHO/2019-nCoV/IPC_masks/2021.1
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
3of38
1.ExecutiveSummary
InfoBox
Version1.0InfectionPreventionandControlinthecontextofcoronavirusdisease(COVID-19):LivingGuideline
ThisfirsteditionoftheInfectionPreventionandControlinthecontextofcoronavirusdisease(COVID-19):LivingGuidelineprovidesthemostuptodatetechnicalguidanceonmaskuseincommunitysettingsinthecontextofCOVID-19.ThislivingguidelineincorporatestheGradingofRecommendations,Assessment,DevelopmentandEvaluations(GRADE)processes(seeMethodologysection)withexisting(previouslypublished)technicalguidanceinMAGICapptoallowuserstoeasilynavigateinfectionpreventionandcontrol(IPC)guidelinesinthedynamicsituationofCOVID-19.Thiseditiontakesintoconsiderationtheevolvingepidemiologicalsituation,includingtheemergenceoftheVoCOmicron.FurtherinformationonOmicronVoCcanbefoundinthefollowingtechnicaldocumentEnhancingReadinessforOmicron(B.1.1.529):TechnicalBriefandPriorityActionsfortheMemberStates,issuedbyWHOon17December2021[1].
Thisdocumentisalivingguideline,whereupdatedornewstatementswillbeaddedasnewevidenceemergesthatwillbereviewedthroughtheGRADEprocess.Thus,theguidelineiswritten,disseminated,andupdatedinMAGICapp.Itsuser-friendlyformatandstructureallowforeasynavigationwhileaccommodatingforthedynamicnatureoftheCOVID-19publichealthemergencyandassociatedevidenceandrecommendations.MAGICAppallowshighlightingofnewandupdatedstatementswhilekeepingexistingstatementsandsupportingevidencewithintheguideline.Thestatementsaremarkedwithdifferentlabelsandcolourcodingtoreflectthedifferentconsolidationapproachesofexistingguidance,updates,andnewstatements.
Inthisedition,newinformationincludesupdatedmaskrecommendationsforthegeneralpublic,astatementonpoliciesforappropriateadherencetoacomprehensivepackageofpreventivemeasurestoreducesevereacuterespiratorysyndromecoronavirus2(SARS-CoV-2)transmission,astatementonthetypeofmasktobeusedbyhigher-riskindividuals,andimplementationconsiderationsforthetypeandminimumessentialparametersofmasksusedincommunitysettings.
ThepreviouslypublishedtechnicalguidancedocumentsincorporatedinVersion1.0areasfollows:
1.
MaskuseinthecontextofCOVID-19-December2020
;and
2.
AdviceontheuseofmasksforchildreninthecontextofCOVID-19
-August2020;.
TheWorldHealthOrganization(WHO)recommendstheuseofmasksaspartofacomprehensivepackageofpreventionandcontrolmeasurestolimitthespreadofSARS-CoV-2,thevirusthatcausesCOVID-19.Evenwhenusedcorrectly,amaskaloneisinsufficienttoprovideadequateprotectionorsourcecontrol.Otherpublichealthandsocialmeasuresincludetesting,isolation,contacttracing,quarantine,adequateventilationinindoorsettings,aphysicaldistancingofatleast1metre,handhygiene,andrespiratoryetiquette.Together,thesemeasuresarecriticaltopreventhuman-to-humantransmissionofSARS-CoV-2.Thisdocumentguidesdecision-makers,publichealthandIPCprofessionals,childhealthprofessionalsandnon-medicalmaskmanufacturers.
1.1Abbreviations
aOR
adjustedoddsratio
COVID-19
coronavirusdisease2019
CI
ConfidenceInterval
EtD
EvidencetoDecision
GDG
GuidelineDevelopmentGroup
GRADE
GradingofRecommendations,Assessment,DevelopmentandEvaluations
ILI
Influenza-likeillness
IPA
InternationalPaediatricAssociation
IPC
infectionpreventionandcontrol
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
4of38
NIOSH
NationalInstituteforOccupationalSafetyandHealth
OR
oddsratio
PPE
personalprotectiveequipment
SARS-CoV
severeacuterespiratorysyndromecoronavirus
SARS-CoV-2
severeacuterespiratorysyndromecoronavirus2
UNICEF
UnitedNationsChildren'sFund
UK
UnitedKingdom
USA
UnitedStatesofAmerica
WHO
WorldHealthOrganization
VoC
VariantofConcern
1.2Definitions
Definitions
Healthworkersareallpeopleprimarilyengagedinactionswiththeprimaryintentofenhancinghealth.Examplesarenursingandmidwiferyprofessionals,doctors,cleaners,otherstaffwhoworkinhealthfacilities,socialworkersandcommunityhealthworkers.
Medicalmasksaredefinedassurgicalorproceduremasksthatareflatorpleated,andtheyareaffixedtotheheadwithstrapsaroundtheears,head,orboth.Theirperformancecharacteristicsaretestedaccordingtoasetofstandardizedtestmethods(ASTMF2100,EN14683,orequivalent)thataimtobalancehighfiltration,adequatebreathabilityand,optionally,fluidpenetrationresistance[5][121].
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
5of38
2.Methodology
Methodologyfordevelopingthestatements
StatementsincludedinthisdocumentarebasedonpublishedWHOguidelines(inparticular,theWHOGuidelinesoninfectionpreventionandcontrolofepidemic-andpandemic-proneacuterespiratoryinfectionsinhealthcare)andongoingevaluationsofallavailablescientificevidencebyWHOCOVID-19IPCGuidanceDevelopmentGroup(GDG)(seeAcknowledgements).Thisevidenceisevaluatedthroughexpeditedsystematicreviewsandexpertconsensus-buildingthroughregularGDGconsultationsfacilitatedbyamethodologist.Whenfurtherclarityorconsensusisnecessary,meetingsarefollowedupbyavotingprocessbytheGDGmembers.Recommendationsarebasedonanassessmentofthebalanceofbenefitstoharmsaswellascertaintyintheseassessments.Thisprocessalsoconsiders,asmuchaspossible,potentialresourceimplications,valuesandpreferences,feasibility,equityandethics.Anexternalreviewpanelofexpertsreviewsdraftguidancedocumentsbeforepublication.
Methodologyfordevelopingthislivingguideline
Asdescribedintheexecutivesummary,giventhedynamicsituationoftheCOVID-19pandemic,thisfirsteditionofthislivingguidelinecombinesexistingguidanceformulatedthroughexpertreviewofevidence,theGRADEevidence-to-decision(EtD)framework,andstandardsfortrustworthyguidelines.ForrecommendationsfollowingtheGRADEEtDframework,aGDGcomprisedofindividualswithbroadexpertisespanningmultiplespecialtiesacrossallWHOregions(seeAcknowledgements)wasconvenedovermultiplemeetingswhereGDGmembersreachedagreement(throughconsensusorvotewithsupermajority)onthestatements.
ManagingConflictsofInterest
AfteranalyzingtheDeclarationofInterestformsandconductingtherequiredinternetsearch,WHOconcludednomemberhadfinancialorcommercialinterestsrelatedtoCOVID-19andmasks.Methodsarealignedwith
WHOHandbookforguidelinedevelopment
.
Readershipcuesforapproachesusedtodevelopstatements
Giventheconsolidationprocess,thestatementsaremarkedwithdifferentlabelsandcolourcodestoreflectthesetwoapproaches.ThegreencheckmarksreflectstatementsthatweredevelopedusingtheGRADEEtDframework.PurplecheckmarksrefertostatementsthathavenotgonethroughtheGRADEEtDframeworkprocessbutareinformedbyevidencereviewandaretheproductofexpertconsensus.Thegreybarreferstoimplementationconsiderationswhichsupportstatementsthroughpracticaladvice,andaretheproductofexpert
consensus.
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
6of38
GRADEEtDFramework
GRADEratesscientificevidencetodevelopevidence-basedguidelines.Eachrecommendationisassignedastrengthofrecommendationandqualityofevidence.
GRADEevidenceprofilescontainanassessmentofthequalityoftheevidenceandasummaryoffindingsforeachcriticaloutcomeandeachkeyquestion.TheGDGusesthesesummariesasthebasisfordiscussionsandformulationofrecommendations.
Goodpracticestatementsandimplementationconsiderations
Goodpracticestatementsindicateactionsthatshouldbeimplemented,inmostcircumstances,whenthecertaintysurroundingtheeffectestimatesishigh,butthesupportiveevidenceisindirect.Benefitsarebasedonmultiplebodiesofindirectevidence,oftenchallengingtoreviewsystematically.Goodpracticestatementsaregenerallyreservedforconsiderationswithwidespreadconsensusandwhentheinterventioniswidelyaccepted.Implementationconsiderationsarecriticalelementsthatfacilitatetheappropriateuseofformalstatements.
Timeline
AnexternallivingsystematicreviewhasbeencommissionedtocontinuouslymonitoremergingevidenceontheuseofmasksinthecontextoftheCOVID-19publichealthemergencyofinternationalconcern.Theemergingevidencewilltriggercontinuousupdatesastheneedisidentified.
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
7of38
3.Advice,statementsandrecommendations
3.1Generalmaskadvice
InfoBox
Maskmanagement
Foranytypeofmask,appropriateuse,storage,cleaningordisposalareessentialtoensurethattheyareaseffectiveaspossibleandtoavoidanyincreasedriskoftransmission.Adherencetocorrectmaskmanagementpracticesvaries,reinforcingtheneedforappropriatemessaging[115].WHOprovidesthefollowingguidanceonthecorrectuseofmasks:
?Washhandsthoroughlybeforeputtingonthemask.
?Inspectthemaskfortearsorholes,anddonotuseadamagedmask.
?Placethemaskcarefully,ensuringitcoversthemouthandnose,adjusttothenosebridgeandtieitsecurelytominimizeanygapsbetweenthefaceandthemask.Ifusingearloops,ensurethesedonotcrossoverasthiswidensthegapbetweenthefaceandthemask.
?Avoidtouchingthemaskwhilewearingit.Ifthemaskisaccidentlytouched,washhandsthoroughly.
?Removethemaskusingtheappropriatetechnique.Donottouchthefrontofthemask;rather,untieitfrombehind.
?Replacethemaskassoonasitbecomesdampwithanew,cleananddrymask.
?Eitherdiscardthemaskorplaceitinacleanplasticresealablebagwhereitiskeptuntilitcanbewashedandcleaned.Donotstorethemaskaroundthearmorwristorpullitdowntorestaroundthechinorneck.
?Washhandsimmediatelyafterdiscardingamask.
?Donotreusesingle-usemasks.
?Discardsingle-usemasksaftereachuseandproperlydisposeofthemimmediatelyuponremoval.
?Donotremovethemasktospeak.
?Donotshareyourmaskwithothers.
?Washfabricmasksinsoapordetergentandpreferablyhotwater(atleast60°Centigrade/140°Fahrenheit)atleastonceaday.Ifitisnotpossibletowashthemasksinhotwater,thenwashthemaskinsoap/detergentandroom-temperaturewater,followedbyboilingthemaskfor1minute.
?Amaskshouldbechangedtoacleanmaskatleastoncedaily.
Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.
Exhalationvalvesonrespiratorsandnon-medicalmasksarediscouragedastheydonotallowforadequatesourcecontrolfromthewearer.Exhalationvalvespermitbypassofthefiltrationlayerswhenthewearerexhales,potentiallyallowingpass-throughofinfectiousparticles.
Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.
3.2Maskuseincommunitysettings
8of38
InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2
Updated
Strongrecommendationfor,Moderatecertaintyevidence
InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2,irrespectiveofvaccinationstatusorhistoryofpriorinfection,wearingawell-fittingmask*thatcoversthenoseandmouthisrecommendedforthegeneralpublicwheninteractingwithindividualswhoarenotmembersoftheirhousehold:
?inindoorsettingswhereventilationisknowntobepoororcannotbeassessed,ortheventilationsystemisnotproperlymaintained,regardlessofwhetherphysicaldistancingofatleast1metrecanbemaintained1;
?inindoorsettingsthathaveadequateventilationifphysicaldistancingofatleast1metrecannotbemaintained*;or
?inoutdoorsettingswherephysicaldistancingofatleast1metrecannotbemaintained*.
*Masktypesinclude:
?reusable,non-medicalmasksthatcomplywiththe
ASTMF3502
standardor
CENWorkingAgreement17553
,oranon-medicalmaskmeetingWHOessentialparameters(seepracticalinfoformoreinformation).;
?disposablemedicalmasks,complyingwithmedicalmaskstandardsEN14683TypeI,ASTMF2100Level1,YY/T0969,YY0469(orequivalent)iftheavailabilityofmedicalmasksmeetingminimumperformancecriteriaforhealthworkershasbeenassured**;
?iftheaboveoptionsarenotavailable,othertypesofwell-fittingnon-medicalmasksincludinghomemademultilayeredmasks***areanacceptableoption(accordingtolocalpolicies).
1Physicaldistanceshouldbeincreasedbeyond1metrewheneverfeasible.
Updated22December2021.
PracticalInfo
Forinformationonassessingandimprovingindoorventilation,pleaseseeWHO's
Roveensureg
oadmaptoimprandoodindoor
venconoCOVID-19
tilationinthetextf.
Practicalconsiderationsforpolicy-makers:
Thepotentialadvantagesofmaskusebyhealthypeopleinthegeneralpublicinclude:
?reducedspreadofpotentiallyinfectiousaerosolsordropletsfromexhaledbreath,includingfrominfectedpeoplebeforetheydevelopsymptoms[15];
?encouragingconcurrenttransmissionpreventionbehaviourssuchaswashinghandsandnottouchingtheeyes,noseandmouth[16][17][18];and
?preventingtransmissionofotherrespiratoryillnessessuchastuberculosisandinfluenzaandreducingtheburdenofthesediseasesduringthepandemic[19].
Thepotentialdisadvantagesofmaskusebyhealthypeopleinthegeneralpublicinclude:
?headacheand/orbreathingdifficulties,dependingonthetypeofmaskused[12];
?developmentoffacialskinlesions,irritantdermatitisorworseningacnewhenusedfrequentlyforlonghours[13][20];
?difficultywithcommunicatingclearly,especiallyforpersonswhoaredeaforhavepoorhearingoruselipreading[21][22];
?poorcompliancewithmask-wearing,inparticularbyyoungchildren[24][25][26][27];
?wastemanagementissues;impropermaskdisposalleadingtoincreasedlitterinpublicplacesandenvironmentalhazards[28];and
?furtherdisadvantagesfor,ordifficultywearingmasksby,certainmembersofthepopulation,especially:children;
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
9of38
developmentallychallengedpeople;thosewithmentalillnessorcognitiveimpairment;thosewithasthma,chronicrespiratoryorbreathingproblems;thosewhohavehadfacialtraumaorrecentoralmaxillofacialsurgery;andthoselivinginhotandhumidenvironments[12][25].
EvidenceToDecision
Benefitsandharms
Substantialnetbenefitsoftherecommendedalternative
TheutilizationofmasksincommunitysettingsislikelyassociatedwithadecreasedriskofSARS-CoV-2infectionscomparedwithnomask-wearing.SARS-CoV-2B.1.617.2(Delta)varianthasbeenreportedtohaveincreased
transmissibility[29][30][31][33][32];mostGDGmembers,therefore,agreedthat,inthecontextoftheDeltavariant,thebenefitsofmask-wearinginthecommunitysettingoutweighpotentialharms.EcologicalstudieshaveidentifiedanassociationwithdecreasednumberofconfirmedcasesofCOVID-19andpoliciesrequiringtheuseofmasks[34][35][36].Aclusterrandomizedcontrolledtrialevaluatingmaskpromotion(asanindirectpublichealthintervention)foundthatinacountrywithlowmaskuse,maskpromotionincreasedmaskuseanddecreasedsymptomaticSARS-CoV-2seroprevalence[37].Conversely,anotherrandomizedcontrolledtrialfoundnostatisticalsignificanceassociatedwithsurgicalmaskuseandareducedriskofSARS-CoV-2[38].Thestudyprovidedanimpreciseestimateformaskutilizationversenoutilization;however,thestudywasnotdesignedtoevaluatetheeffectivenessofmaskuseforsourcecontrol.
ManyGDGmembersnotethat,eventhoughthecertaintyoftheevidenceismoderate,thereisasubstantialneedforWHOtoproducecohesiveandrobustrecommendations,asthenetbenefitsofmaskusebythegeneralpublicoutweighthepotentialharms.
Moderate
CertaintyoftheEvidence
Balanceofdesirableandundesirableoutcomes.
Preferenceandvalues
Nosubstantialvariabilityexpected
DiscussionswithstakeholdersandIPCGDGmembershaveindicatedageneralpreferencetofavourmaskuseincommunitysettings.ManyGDGmembersnotethat,inthecontextoftheDeltavariantandothervariantsofconcern,maskingisavitalSARS-CoV-2mitigationmeasure.Membersexpressedaneedtodocumentaclearopinionontheuseofmasksincommunitysettings,giventheimpactoflocalandnationalvaluesandpreferencesonIPCpolicies.Giventheavailabilityofmasks,communitymaskingislikelyfeasible.
Resourcesandotherconsiderations
Noimportantissueswiththerecommendedalternative
ManyGDGmembersnotedtheglobalsupplychainformaskmanufacturinghasimprovedandwouldnotposeasevereobstacletocommunitymasking.Thecostofbothmedicalmasksandnon-medical(fabric)masksarerelativelylow,anddonotposeasubstantialbarrierforlow-andmiddle-incomecountries.
Gapsinknowledgeandresearchneeds
Investigationsontheutilizationofmasksinthecommunitysettingareongoing;however,publishedworkhasidentifiedtheneedforcontinuedresearch.Wellconductedobservationalstudiesand/orrandomizedcontrolledtrialsexploringtheuseofmasksversusnomasksinvarioussettings(e.g.indoor,outdoor,ventilationstatus,etc.)wouldfurtherclarifyoutstandinginquiriesconcerningmaskuseincommunitysettings.Inaddition,researchinvestigatingtheuseofmasks(includingtypeofmaskandtransmissionscenarios)inthecontextoftheDeltavariantwouldprovidepowerfulevidenceforfuturerecommendations.However,GDGmembersdiscussedthechallengesassociatedwithobtainingcompellingevidencefromarandomizedcontrolledtrialonbehaviouralinterventions.Furthermore,withtheavailabilityofaSARS-CoV-2inoculation,furtherresearchwillbeneededtoreinforcetheimpactofvaccinationonmaskutilizationincommunitysettings.
WHOInfectionPreventionandControlCOVID-19LivingGuideline-Maskuseincommunitysettings-WorldHealthOrganization(WHO)
10of38
Justification
GDGmemberswereaskedtoevaluatethestrengthoftheproposedrecommendation(strongrecommendationversusconditionalrecommendation).Basedontheavailableevidence,theGRADEprocessandtheEvidencetoDecisionframework,theIPCGDGagreedonastrongrecommendation.TheopinionoftheGDGwassolidifiedviaanonlinesurvey,inwhich82.1%(23/28)ofGDGmembersvotedforastrongrecommendationand17.9%(5/28)votedforaconditionalrecommendation.
New
Goodpracticestatement
InsettingswherethereiscommunityorclustertransmissionofSARS-CoV-2,policiesshouldbedeveloped,strengthenedandimplementedtoencourageappropriateadherencetoacomprehensivepackageofpreventivemeasurestoreducetransmission(ventilation,physicaldistance,handhygiene,andrespiratoryetiquette)includinginparticular,maskadherencebythegeneralpublic.
Updated22December2021.
Justification
GDGmemberswereinitiallyaskedifWHOshoulddevelopastatementontheimportanceofmask-wearingand/orinterventionstoimproveadherencetomask-wearingguidance;however,manymembersthoughtitwasessentialtoconsiderthe“bundle”ofpublichealthsocialmeasuresthatpertaintothegeneralpublic.Theabovegoodpracticestatementwasdeterminedbyanonlinevote,where27GDGmembersresponded,with55.6%(15)votingforthestatementasmentionedabove,whiletheremaining44.4%(12)votedforslightlydifferentwordingforthegoodpracticestatement.
InalltransmissionscenariosofSARS-CoV-2
InfoBox
Updated
Implementationconsideration
Inareaswithknownorsuspectedsporadictransmission,ornodocumentedtransmission,WHOadvisethatdecision-makersshouldapplyarisk-basedapproachfocusingonthefollowingcriteriawhenconsideringtheuseofmasksforthegeneralpublic:
?purposeofmaskuse;
?riskofexposuretoSARS-CoV-2;
?vulnerabilityofthemaskwearer/population;
?settinginwhichthepopulationlives;
?feasibility;
?typeofmask;
?vaccinationcoverage;and
?circulatingvariantsofconcern.
Updated22December2021.
Justification
GDGmembersnotedtheimportanceofincludingvaccinationcoverageandcirculatingvariantsofconcerntotheimplementation
11of38
considerationsgiventheavailabilityofvaccinationandthecurrentlandscapeofSARS-CoV-2transmission.
Inanytransmissionscenario,personswithanysymptomssuggestiveofCOVID-19shouldwearamedicalmaskandadditionally:
?self-isolateandseekmedicaladviceassoonastheystarttofeelunwellwithpotentialsymptomsofCOVID-19(evenifsymptomsaremild);
?followinstructionsonhowtoputon,takeoffanddisposeofmedicalmasksandwashhandsthoroughly[39];
?followalladditionalmeasures,inparticular,respiratoryhygiene,frequenthandwashingandmaintainingaphysicaldistanceofatleast1metrefromotherpersons[75].
?IfamedicalmaskisnotavailableforindividualswithsuspectedorconfirmedCOVID-19,afabricmaskwithfit,filtrationandbreathabilityassessedtomeetWHO'sessentialparametersfornon-medicalmasksshouldbewornbypatientsasasourcecontrolmeasure,pendingaccesstoamedicalmask.Theuseofanon-medicalmaskcanminimizetheprojectionofrespiratoryparticlesfromtheuser[40][41]
AsymptomaticpersonswhotestpositiveforSARS-CoV-2shouldwearamedicalmaskwhenwithothersforaperiodof10daysaftertestingpositive.
Extractedfromtheguidancetitled“MaskuseinthecontextofCOVID-19”,published1December2020.
EvidenceToDecision
CertaintyoftheEvidence
Evidenceontheprotectiveeffectofmaskuseincommunitysettings
Atpresent,thereisonlylimitedandinconsistentscientificevidencetosupporttheeffectivenessofmaskinghealthypeopleinthecommunitytopreventinfectionwithrespiratoryviruses,includingSARS-CoV-2[6].Alargerandomizedcommunity-basedtrialinwhich4862healthyparticipantsweredividedintoagroupwearingmedical/surgicalmasksandacontrolgroupfoundnodifferenceininfectionwithSARS-CoV-2[42].Arecentsystematicreviewfoundninetrials(ofwhicheightwerecluster-randomizedcontrolledtrialsinwhichclustersofpeople,versusindividuals,wererandomized)comparingmedical/surgicalmasksversusnomaskstopreventthespreadofviralrespiratoryillness.Twotrialsinvolvedhealthcareworkersandsevenhadcommunity-basedparticipants.ThereviewconcludedthatwearingamaskmaymakelittleornodifferencetothepreventionofILI(RR:0.99;95%CI:0.82–1.18)orlaboratory-confirmedinfluenza(LCI)(RR:0.91;95%CI:0.66–1.26)[11];thecertaintyoftheevidencewaslowforILI,moderateforLCI.
Bycontrast,asmallretrospectivecohortstudyfromBeijingfoundthatmaskusebyentirefamiliesbeforethefirstfamilymemberdevelopedCOVID-19symptomswas79%effectiveinreducingtransmission(oddsratio(OR):0.21;CI0.06-0.79)[43].Acase-controlstudyfromThailandfoundthatwearingamedicalornon-medicalmaskallthetimeduringcontactwithaCOVID-19patientwasassociatedwitha77%lowerriskofinfection(adjustedoddsratio(aOR)0.23;95%CI0.09–0.60)[44].SeveralsmallobservationalstudieswithepidemiologicaldatahavereportedanassociationbetweenmaskusebyaninfectedpersonandthepreventionofonwardstransmissionofSARS-CoV-2infectioninpublicsettings[2][45][46][47].
Anumberofstudies,somepeer-reviewedbutmostpublishedaspre-prints,reportedadeclineinthenumberofCOVID-19casesassociatedwithfacemaskusebythepublic,usingcountry-orregion-level
data.[48][49][50][51][52][53][54][55][56][57][58][59][60][61][62][63][64][65][66][67][68][69].Onestudyreportedanassociationbetweencommunitymask-wearingpolicyadoptionandincreasedmovement(lesstimeathome,increasedvisitstocommercial
12of38
locations)[23].Thesestudiesdifferedinsetting,datasourcesandstatisticalmethods,andhaveimportantlimitationstoconsider[70],notablythelackofinformationaboutactualexposureriskamongindividuals,adherencetomask-wearingandtheenforcementofotherpreventivemeasures[71][72].
Studiesofinfluenza,ILIandhumancor
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預覽,若沒有圖紙預覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責。
- 6. 下載文件中如有侵權(quán)或不適當內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 電動汽車行業(yè)財務績效評價體系研究
- 2025至2031年中國水玫瑰潤膚露行業(yè)投資前景及策略咨詢研究報告
- 2025至2031年中國室內(nèi)/外云臺行業(yè)投資前景及策略咨詢研究報告
- 2025至2031年中國塑料加料機行業(yè)投資前景及策略咨詢研究報告
- 2025年含油子仁項目合作計劃書
- 2025至2030年中國遠距離全向讀感器數(shù)據(jù)監(jiān)測研究報告
- 雜貨間出租合同范本
- 班級文化傳承與空間環(huán)境的融合
- 2025至2030年中國滾筒篩數(shù)據(jù)監(jiān)測研究報告
- 門店轉(zhuǎn)讓房合同范本
- DL∕T 2024-2019 大型調(diào)相機型式試驗導則
- 大酒店風險分級管控和隱患排查治理雙體系文件
- 2024年蘇州市職業(yè)大學單招職業(yè)適應性測試題庫附答案
- (高清版)JTGT 3610-2019 公路路基施工技術(shù)規(guī)范
- 術(shù)后惡心嘔吐防治專家意見
- MOOC 醫(yī)學免疫學-南昌大學 中國大學慕課答案
- JB-T 8640-2014 額定電壓26-35kV及以下電力電纜附件型號編制方法
- 社會保障卡辦理委托書
- 微積分(第三版)課件:多元函數(shù)微積分
- 2024年青海公務員考試行測真題及答案
- 山東職業(yè)學院單招《英語》考試復習題庫(含答案)
評論
0/150
提交評論